Trends in Radical Prostatectomy Risk Group Distribution in a European Multicenter Analysis of 28 572 Patients: Towards Tailored Treatment.
暂无分享,去创建一个
H. G. van der Poel | F. Montorsi | L. Salomon | R. V. D. van den Bergh | M. Graefen | G. Gandaglia | A. Briganti | P. Sooriakumaran | A. De la taille | P. Ost | D. Tilki | C. Surcel | M. Valerio | G. Ploussard | H. Borgmann
[1] P. Stattin,et al. Uptake of Active Surveillance for Very-Low-Risk Prostate Cancer in Sweden , 2017, JAMA oncology.
[2] H. G. van der Poel,et al. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. , 2017, European urology.
[3] David Gillatt,et al. 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer. , 2017, The New England journal of medicine.
[4] M. Roobol,et al. A Decade of Active Surveillance in the PRIAS Study: An Update and Evaluation of the Criteria Used to Recommend a Switch to Active Treatment. , 2016, European urology.
[5] J. Hugosson,et al. Long-term Results of Active Surveillance in the Göteborg Randomized, Population-based Prostate Cancer Screening Trial. , 2016, European urology.
[6] R. Walters,et al. Trends in the use of radiation therapy for stage IIA prostate cancer from 2004 to 2013: a retrospective analysis using the National Cancer Database , 2016, Prostate Cancer and Prostatic Diseases.
[7] Ronald C. Chen,et al. Active Surveillance for the Management of Localized Prostate Cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] Hartwig Huland,et al. Changing Trends in Surgical Management of Prostate Cancer: The End of Overtreatment? , 2015, European urology.
[9] M. Cooperberg,et al. Trends in Management for Patients With Localized Prostate Cancer, 1990-2013. , 2015, JAMA.
[10] N. Lawrentschuk,et al. The current use of active surveillance in an Australian cohort of men: a pattern of care analysis from the Victorian Prostate Cancer Registry , 2015, BJU international.
[11] M. Menon,et al. The role of robot-assisted radical prostatectomy and pelvic lymph node dissection in the management of high-risk prostate cancer: a systematic review. , 2014, European urology.
[12] Jennifer R. Rider,et al. Radical Prostatectomy or Watchful Waiting in Early Prostate Cancer , 2014 .
[13] M. Cooperberg,et al. Active surveillance for prostate cancer: a systematic review of the literature. , 2012, European urology.
[14] L. Holmberg,et al. Individualized estimation of the benefit of radical prostatectomy from the Scandinavian Prostate Cancer Group randomized trial. , 2012, European urology.
[15] Angela Mariotto,et al. Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context. , 2009, Journal of the National Cancer Institute.
[16] R. V. D. van den Bergh,et al. Prospective validation of active surveillance in prostate cancer: the PRIAS study. , 2007, European urology.
[17] T. H. van der Kwast,et al. Management and survival of screen-detected prostate cancer patients who might have been suitable for active surveillance. , 2006, European urology.
[18] Neil Fleshner,et al. Feasibility study: watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progression. , 2002, The Journal of urology.
[19] Guy Vallancien,et al. Robotically Assisted Laparoscopic Radical Prostatectomy: Feasibility Study in Men , 2001, European Urology.
[20] A. D'Amico,et al. A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer. , 1995, The Journal of urology.
[21] David C. Miller,et al. Contemporary use of initial active surveillance among men in Michigan with low-risk prostate cancer. , 2015, European urology.
[22] Timothy J Wilt,et al. Radical prostatectomy versus observation for localized prostate cancer. , 2012, The New England journal of medicine.